| __timestamp | Pharming Group N.V. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 4042025 | 4241601.57 |
| Thursday, January 1, 2015 | 5279557 | 5392385.38 |
| Friday, January 1, 2016 | 8073913 | 7370036.73 |
| Sunday, January 1, 2017 | 44864073 | 14970357 |
| Monday, January 1, 2018 | 53488904 | 31413266 |
| Tuesday, January 1, 2019 | 65896361 | 72279461 |
| Wednesday, January 1, 2020 | 69968267 | 183907682 |
| Friday, January 1, 2021 | 92047281 | 307644000 |
| Saturday, January 1, 2022 | 131819000 | 472132000 |
| Sunday, January 1, 2023 | 87501000 | 709539000 |
Unleashing the power of data
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for sustaining growth and innovation. Over the past decade, argenx SE and Pharming Group N.V. have taken distinct paths in optimizing these costs. From 2014 to 2023, argenx SE's SG&A expenses surged by over 16,600%, reflecting its aggressive expansion strategy. In contrast, Pharming Group N.V. saw a more modest increase of approximately 2,100%, indicating a more conservative approach.
In 2014, both companies started with similar SG&A expenses, but by 2023, argenx SE's costs had outpaced Pharming Group N.V. by a factor of eight. This divergence highlights argenx SE's focus on rapid growth, while Pharming Group N.V. maintained a steadier course. As these companies continue to evolve, their financial strategies will play a pivotal role in their future success.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and argenx SE
argenx SE or Alpine Immune Sciences, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of argenx SE and CRISPR Therapeutics AG
Who Optimizes SG&A Costs Better? argenx SE or Bausch Health Companies Inc.
Cost Management Insights: SG&A Expenses for argenx SE and ACADIA Pharmaceuticals Inc.
SG&A Efficiency Analysis: Comparing Insmed Incorporated and Pharming Group N.V.
Ascendis Pharma A/S and Pharming Group N.V.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Pharming Group N.V. and CymaBay Therapeutics, Inc.
Breaking Down SG&A Expenses: Pharming Group N.V. vs Veracyte, Inc.
Pharming Group N.V. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Pharming Group N.V. and Ligand Pharmaceuticals Incorporated
Comparing SG&A Expenses: Pharming Group N.V. vs Dynavax Technologies Corporation Trends and Insights